PLASTIQ

Are we about to reverse aging? In this episode, we break down the first-ever FDA-approved human trial targeting cellular rejuvenation, the billion-dollar race led by Altos Labs and Jeff Bezos, and whether drugs like GLP-1s, rapamycin, and SGLT2 inhibitors could secretly extend lifespan. Science fiction is becoming reality—are we closer than ever to curing aging?

Are SCIP, SIEA, and PAP flaps about to replace your go-to reconstructive options? Should you be doing pre-pectoral implants over sub-pectoral? And is AI actually useful in your OR — or just another tech buzzword?In this episode we break down five fresh 2025 papers covering the biggest shifts in flap selection, breast reconstruction, and surgical technology. We cover the emerging SCIP/SIEA/PAP flaps and why they're being called the new workhorses for soft tissue reconstruction across all body regions, the latest on robotic-assisted LD flap and pre-pectoral reconstruction, and a concept most surgeons never learned in residency — flap autonomization, and why understanding its timeline actually matters for your postoperative decisions. We also cut through the AI hype with a 15-year systematic review on what machine learning can and can't do in plastic surgery, and wrap with a surprising RCT showing 3D telemedicine genuinely outperforms 2D for reconstructive follow-up.Essential listening for anyone who operates with flaps or is curious about where the specialty is heading.

In this episode, we dive into five cutting-edge papers that are collectively reshaping what's possible in plastic and reconstructive surgery. We start with the robots — and we mean it. Two systematic reviews and a narrative review converge on the same conclusion: robotic microsurgery is no longer a novelty. We break down what the Symani and Da Vinci platforms are actually delivering in DIEP flap harvest, lymphovenous anastomosis (LVA), and nipple-sparing mastectomy — with real outcome data including smaller fascial incisions, 100% patency in sub-0.3 mm vessels, and meaningful limb volume reduction in lymphedema patients. Is robotic LVA ready for your OR? We weigh in.

What if the most attractive faces are the ones you barely notice?In this episode, we reveal the surprising science behind beauty—and why your brain is wired to ignore perfection but fixate on flaws. From eye-tracking studies that expose how we actually look at faces, to the disturbing rise of “Snapchat dysmorphia,” this episode dives into how social media is quietly reshaping what we think is beautiful.But that’s just the beginning.We also uncover the next generation of aesthetic medicine—where plastic surgery is no longer just about cutting and reshaping, but about regenerating tissue at a cellular level. Think stem cells, exosomes, and treatments that don’t just make you look younger—but may actually make your cells behave younger.And yes—AI is already entering the room.

GLP-1 medications like Ozempic and Wegovy have taken the world by storm—but what if weight loss is just the beginning?In this episode, we dive into the rapidly evolving science behind GLP-1 receptor agonists. Beyond their role in treating Type 2 Diabetes and obesity, new research suggests they may impact cardiovascular health, inflammation, addiction pathways, and even aging.

Beauty is entering the biotech era. Infrared technology, barrier-repair formulations, and multi-treatment pods are shifting the focus from covering flaws to rebuilding skin at a biological level. In this episode, we explore how aging itself is becoming something we can engineer — not just treat.

Forget moisturizers — the real transformation is coming from devices. From next-gen radiofrequency tightening (like XERF) to needle-free microneedling chips, beauty is becoming hardware. We explain the science behind how these technologies stimulate collagen, penetrate skin barriers, and deliver real results — fast.

AI is turning your skin into data. From at-home scanners that analyze wrinkles, pigmentation, and hydration to algorithms that predict how you’ll age — beauty is becoming predictive. In this episode, we break down how AI diagnostics actually work and why this might replace dermatologists for everyday decisions.

For decades, the message was clear: genetics plays a small role — about 20% — while lifestyle choices like diet, exercise, and habits determine the rest. But emerging research is challenging that idea, suggesting genetics may account for closer to 50% of how long we live, and an even greater share of dementia risk.So what does that actually mean?

It was invented to stop organ rejection. Then scientists discovered it extends lifespan in mice by up to 26%. Now dermatologists are applying it to aging skin in cream form — and the results are documented in randomized clinical trials. This week: the rapamycin revolution nobody is talking about yet, the new science of "skinspan," why longevity medicine and plastic surgery are fully merging, and what a $30 fermented wheat supplement has to do with your collagen. The future of not aging is weirder and more exciting than you think.

This week on PLASTIQ, we're diving into two of the most talked-about — and most misunderstood — topics in aesthetics right now.First: plastic surgery deserts. Did you know that millions of people across the US live in areas with little to no access to board-certified plastic surgeons? We break down where these gaps exist, why they happen, and what it means for patients who want safe, quality care.Then: the filler myth. Dermal fillers have exploded in popularity — but are they really the "non-surgical alternative" they're marketed as? We cut through the hype and get into what fillers can and can't do, who should (and shouldn't) get them, and why so many people end up disappointed.Free, weekly, and always on trend — this is PLASTIQ.

Four stories this week. One involves fish DNA being needled into the faces of A-list celebrities and it genuinely works according to peer-reviewed research. One involves a Botox that kicks in in eight hours and disappears in two weeks. One is about why the neck became the hottest body part in plastic surgery seemingly overnight. And one is a warning about a $52 million verdict that every listener needs to hear before they ever book a cosmetic procedure anywhere. Let's start with the fish.

What if your surgeon could see exactly how your face will look in 20 years — before they make a single cut?This week we're leaving Beverly Hills behind and flying to Istanbul, the city quietly becoming the most technologically advanced hub in plastic surgery on earth. We explore the rise of Computational Aesthetics — the movement replacing surgical guesswork with algorithmic precision — and the Digital Twin: a hyper-realistic 3D replica of your face and body that can simulate your surgical results, predict how your skin will scar, and show you what your new nose looks like at age 60, not just next month.We also go inside the lab of microsurgeon Dr. Burak Sercan Erçin, whose robotic system — the Symani Surgical System — operates on blood vessels just 0.3mm wide. That is thinner than a human hair. The robot filters out the natural tremor of the human hand to perform procedures no unassisted surgeon could physically execute. We break down exactly what that means for reconstruction, replantation, and the future of surgery at a scale the naked eye can barely see.Plus: how AI is being used to engineer the "Alpha Male" aesthetic — analyzing bone structure, jaw angles, and chin projection to create results that enhance masculine markers with mathematical precision rather than artistic instinct.The future of plastic surgery is not in a Beverly Hills consultation room. It is being built right now in Istanbul, and it looks nothing like what came before.

A brand new study just mapped every "plastic surgery desert" in America — places where thousands are searching for procedures but there isn't a single qualified surgeon within reach. Meanwhile researchers proved most of what you see about plastic surgery on TikTok is medically unreliable. Plus why the shot that dissolves your filler is being completely rethought, and the peptide revolution entering the OR. Four new studies, one wild week.

This one is pure jaw-drop territory. No heavy science — just four stories that make you immediately text someone. We're talking about people freezing their own fat before going on Ozempic like they're making a deposit at a biological bank. We're talking about surgeons reshaping cartilage with electricity instead of scalpels. And we're talking about a body part that nobody used to care about suddenly becoming the most requested procedure of 2026. Let's go.

Everyone's getting Botox at 25 now — but does it actually work? This week we dig into the biggest cultural shift in plastic surgery history: a generation that refuses to age, surgeons operating on younger patients than ever, and the bombshell study that analyzed 15 million social media posts and quietly admitted the science might not back the hype. Plus why subtle is the new dramatic, why men stopped hiding it, and what a facelift at 42 actually looks like in 2026.

How a rogue cancer drug became the hottest thing in anti-aging surgeryYour skin is quietly being destroyed by cells scientists literally call "zombie cells." They stopped working, refuse to die, and spend their time pumping out inflammatory chemicals that break down collagen, slow healing, and make you age faster. The medical term is senescent cells. A new class of drugs called senolytics can hunt them down and kill them — and the implications for plastic surgery are enormous.

Exosomes, 8-Hour Botox, Off-the-Shelf Fat & the AI That Watches Your Nerves